First Trust Advisors LP Protagonist Therapeutics, Inc Transaction History
First Trust Advisors LP
- $108 Billion
- Q4 2024
A detailed history of First Trust Advisors LP transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, First Trust Advisors LP holds 140,951 shares of PTGX stock, worth $5.43 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
140,951
Previous 140,924
0.02%
Holding current value
$5.43 Million
Previous $6.33 Million
14.1%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding PTGX
# of Institutions
254Shares Held
58.9MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$228 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$222 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$212 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$162 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$128 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $1.89B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...